Aptevo Therapeutics - 51 Year Dividend History | APVO
Historical dividend payout and yield for Aptevo Therapeutics (APVO) since 1971. The current TTM dividend payout for Aptevo Therapeutics (APVO) as of May 23, 2022 is $0.00. The current dividend yield for Aptevo Therapeutics as of May 23, 2022 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.023B |
$0.012B |
|
Aptevo Therapeutics Inc. is a biotechnology company which focused on developing oncology and hematology therapeutics. The company's platform consists of ADAPTIR(TM). Its product pipeline includes WinRho (R) SDF, HepaGam B (R), VARIZIG(R) and IXINITY (R) which are in pre-clinical stage. Aptevo Therapeutics Inc. is based in Seattle, Washington.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
